- Home
- SCWO vs BRNS Comparison
SCWO vs BRNS Comparison
Compare SCWO & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCWO
- BRNS
- Stock Information
- Founded
- SCWO 2021
- BRNS 2016
- Country
- SCWO United States
- BRNS United Kingdom
- Employees
- SCWO N/A
- BRNS N/A
- Industry
- SCWO Environmental Services
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- SCWO Utilities
- BRNS Health Care
- Exchange
- SCWO Nasdaq
- BRNS Nasdaq
- Market Cap
- SCWO 49.2M
- BRNS 55.9M
- IPO Year
- SCWO N/A
- BRNS 2021
- Fundamental
- Price
- SCWO $0.41
- BRNS $1.19
- Analyst Decision
- SCWO
- BRNS Strong Buy
- Analyst Count
- SCWO 0
- BRNS 1
- Target Price
- SCWO N/A
- BRNS $3.00
- AVG Volume (30 Days)
- SCWO 19.5M
- BRNS 61.7K
- Earning Date
- SCWO 11-12-2025
- BRNS 11-06-2025
- Dividend Yield
- SCWO N/A
- BRNS N/A
- EPS Growth
- SCWO N/A
- BRNS N/A
- EPS
- SCWO N/A
- BRNS N/A
- Revenue
- SCWO $1,231,413.00
- BRNS $14,969,000.00
- Revenue This Year
- SCWO $5,945.19
- BRNS N/A
- Revenue Next Year
- SCWO $106.82
- BRNS N/A
- P/E Ratio
- SCWO N/A
- BRNS N/A
- Revenue Growth
- SCWO 403.17
- BRNS 1766.46
- 52 Week Low
- SCWO $0.16
- BRNS $0.64
- 52 Week High
- SCWO $1.68
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- SCWO 49.08
- BRNS 41.22
- Support Level
- SCWO $0.35
- BRNS $1.20
- Resistance Level
- SCWO $0.53
- BRNS $1.38
- Average True Range (ATR)
- SCWO 0.08
- BRNS 0.13
- MACD
- SCWO -0.01
- BRNS -0.02
- Stochastic Oscillator
- SCWO 22.30
- BRNS 15.07
About SCWO 374Water Inc.
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.